HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Chul Kim Selected Research

Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)

1/2016Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.
1/2006Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Chul Kim Research Topics

Disease

43Neoplasms (Cancer)
12/2023 - 09/2005
23Pain (Aches)
11/2022 - 12/2003
12Neuralgia (Stump Neuralgia)
11/2022 - 01/2016
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 01/2018
6Infections
11/2023 - 06/2007
6Peripheral Nervous System Diseases (PNS Diseases)
11/2022 - 01/2016
6Inflammation (Inflammations)
01/2022 - 02/2012
5Squamous Cell Carcinoma of Head and Neck
10/2022 - 06/2012
5Fibrosis (Cirrhosis)
06/2022 - 02/2012
4Breast Neoplasms (Breast Cancer)
07/2020 - 09/2013
4Leukemia
06/2020 - 10/2006
4Chronic Pain
08/2018 - 04/2011
3Neoplasm Metastasis (Metastasis)
01/2024 - 01/2016
3IGA Glomerulonephritis (IGA Nephropathy)
01/2018 - 01/2013
3Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 12/2006
3Myocarditis (Carditis)
09/2016 - 02/2012
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2013 - 10/2006
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023 - 01/2006
2Autosomal Dominant Polycystic Kidney (ADPKD)
01/2023 - 07/2022
2Hyperalgesia
03/2022 - 01/2017
2Postherpetic Neuralgia
01/2022 - 05/2018
2Colonic Neoplasms (Colon Cancer)
08/2019 - 12/2017
2Melanoma (Melanoma, Malignant)
10/2018 - 01/2016
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 07/2013
2Mouth Neoplasms (Oral Cancer)
01/2017 - 04/2015
2Type 2 Diabetes Mellitus (MODY)
01/2017 - 09/2013
2Proteinuria
01/2017 - 01/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2016 - 11/2015
2Necrosis
11/2015 - 01/2013
2Hypotension (Low Blood Pressure)
06/2015 - 01/2013
1Lung Neoplasms (Lung Cancer)
01/2024
1Renal Cell Carcinoma (Grawitz Tumor)
12/2023
1Atopic Dermatitis (Atopic Eczema)
11/2023
1COVID-19
11/2023
1Metabolic Diseases (Metabolic Disease)
11/2023

Drug/Important Bio-Agent (IBA)

11indirubinIBA
03/2019 - 09/2005
10Proteins (Proteins, Gene)FDA Link
12/2023 - 07/2005
7pheophorbide aIBA
10/2022 - 09/2011
71-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2022 - 11/2009
7Photosensitizing Agents (Photosensitizers)IBA
10/2022 - 11/2009
6Phosphotransferases (Kinase)IBA
12/2023 - 04/2013
5Peptide Hydrolases (Proteases)FDA Link
11/2023 - 06/2007
5Pregabalin (Lyrica)FDA Link
03/2022 - 01/2013
5Purinergic P2X7 ReceptorsIBA
12/2019 - 10/2006
4Adenosine Triphosphate (ATP)IBA
02/2022 - 10/2006
4Opioid Analgesics (Opioids)IBA
10/2018 - 08/2015
4Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2017 - 11/2009
3Analgesics (Analgesic Drugs)IBA
11/2022 - 01/2017
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
07/2022 - 02/2015
3Ion Channels (Ion Channel)IBA
03/2022 - 04/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2009
3Aurora Kinase AIBA
08/2019 - 04/2017
3Tacrolimus (Prograf)FDA LinkGeneric
01/2018 - 01/2013
3Therapeutic UsesIBA
01/2017 - 06/2012
2Protein Glutamine gamma Glutamyltransferase 2IBA
12/2023 - 06/2022
2imidazoleIBA
12/2023 - 01/2016
2Antineoplastic Agents (Antineoplastics)IBA
12/2023 - 07/2018
2IndazolesIBA
12/2023 - 11/2023
2Immunosuppressive Agents (Immunosuppressants)IBA
11/2023 - 01/2021
2ArrestinIBA
11/2022 - 10/2019
2fms-Like Tyrosine Kinase 3IBA
07/2022 - 05/2019
2Messenger RNA (mRNA)IBA
01/2022 - 01/2017
2Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2022 - 09/2010
2Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 09/2010
2Peptides (Polypeptides)IBA
01/2021 - 04/2015
2NucleotidesIBA
01/2021 - 07/2005
2tyrosine receptor (receptor, tyrosine)IBA
06/2020 - 01/2018
2Lidocaine (Xylocaine)FDA LinkGeneric
08/2019 - 05/2018
2ProdrugsIBA
07/2018 - 01/2017
2Saline SolutionIBA
05/2018 - 09/2010
2LigandsIBA
01/2018 - 03/2014
2EnzymesIBA
12/2017 - 04/2011
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2016 - 01/2006
25-nitro-5'-hydroxyindirubin-3'-oximeIBA
11/2015 - 04/2013
2Nuclear Antigens (Extractable Nuclear Antigens)IBA
11/2015 - 06/2012
2Docetaxel (Taxotere)FDA Link
03/2014 - 09/2013
2Fibronectins (Fibronectin)IBA
03/2014 - 10/2012
2pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA
01/2013 - 07/2005
2Protein Kinases (Protein Kinase)IBA
08/2012 - 01/2009
2NAD (NADH)IBA
04/2011 - 06/2009
1benzimidazoleIBA
12/2023
1Chlorophyll AIBA
11/2023
1Interleukin-4 (Interleukin 4)IBA
11/2023
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
11/2023
1dupilumabIBA
11/2023
1PolyproteinsIBA
11/2023
1Imiquimod (Aldara)FDA LinkGeneric
11/2023

Therapy/Procedure

20Therapeutics
01/2024 - 10/2006
8Photochemotherapy (Photodynamic Therapy)
10/2022 - 11/2009
5Ligation
11/2022 - 01/2017
4Intravenous Administration
02/2022 - 06/2012
4Drug Therapy (Chemotherapy)
01/2017 - 01/2006
3Oral Administration
12/2023 - 01/2021
2Epidural Injections
01/2021 - 01/2017
2Injections
01/2021 - 09/2013
2Lasers (Laser)
10/2018 - 01/2016
2Activities of Daily Living (ADL)
06/2018 - 08/2015
2Conservative Treatment
01/2017 - 04/2016
1Intraperitoneal Injections
12/2023